These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6141270)

  • 1. Increased brain uptake of morphine in the presence of the antihistamine tripelennamine.
    Vadlamani NL; Pontani RB; Misra AL
    J Pharm Pharmacol; 1984 Jan; 36(1):61-3. PubMed ID: 6141270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the combination of tripelennamine and pentazocine at the behavioral and molecular levels.
    Shannon HE; Su TP
    Pharmacol Biochem Behav; 1982 Oct; 17(4):789-95. PubMed ID: 6294681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic potentiation and the distribution of morphine in the presence of triplennamine in mice.
    Bluhm RE; Evans MA; Zsigmond EK
    Life Sci; 1983; 33 Suppl 1():673-6. PubMed ID: 6664243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of pentazocine antinociception by tripelennamine in the rat.
    Yeh SY
    J Pharmacol Exp Ther; 1985 Dec; 235(3):683-9. PubMed ID: 4078730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the interaction of pentazocine and tripelennamine: drug discrimination and mu-receptor binding assay.
    Shook JE; Kallman MJ; Martin BR; Dewey WL
    Pharmacol Biochem Behav; 1984 Dec; 21(6):877-81. PubMed ID: 6097919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of narcotic-induced antinociception by tripelennamine in morphine-tolerant and drug-naive mice.
    Tagashira E; Kachur JF; Carter WH; Dewey WL
    J Pharmacol Exp Ther; 1984 Apr; 229(1):214-7. PubMed ID: 6707938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opiate dependence alters central reward of nalbuphine or pentazocine plus tripelennamine.
    Huston-Lyons D; Bain GT; Kornetsky C
    Eur J Pharmacol; 1989 Oct; 169(1):153-7. PubMed ID: 2599009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate mixed agonist-antagonist interactions with histamine antagonists vs. morphine.
    Hui FW; Sun CL; Hanig JP
    Neurobehav Toxicol Teratol; 1985; 7(5):443-7. PubMed ID: 4080063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of tripelennamine alone and in combination with opiates to produce antinociception in mice.
    Hui FW; Sun CJ; Tocus EC; Hanig JP
    Life Sci; 1983 Apr; 32(14):1531-8. PubMed ID: 6835002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and pharmacokinetic interaction between morphine and haloperidol in the rat.
    Adamus A; Melzacka M; Vetulani J
    Pol J Pharmacol Pharm; 1984; 36(1):51-8. PubMed ID: 6462960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine concentrations in serum, brain and cerebrospinal fluid in the rat after intravenous administration of a single dose.
    Bolander H; Kourtopoulos H; Lundberg S; Persson SA
    J Pharm Pharmacol; 1983 Oct; 35(10):656-9. PubMed ID: 6139435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the binding of [3H][D-Ser2,Thr6]leucine-enkephalin and [3H][D-Pen2,D-Pen5]enkephalin to brain membranes of morphine tolerant-dependent rats.
    Bhargava HN; Gulati A; Rahmani NH
    Eur J Pharmacol; 1991 Sep; 202(3):403-8. PubMed ID: 1660817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentazocine-tripelennamine ("T's and Blues") substitution studies in morphine-dependent rodents.
    Tagashira E; Kachur JF; Carter WH; Dewey WL
    J Pharmacol Exp Ther; 1984 Oct; 231(1):97-101. PubMed ID: 6541694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats.
    Bhargava HN; Gulati A
    Eur J Pharmacol; 1990 Nov; 190(3):305-11. PubMed ID: 2176984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma, cardiac tissue and brain morphine concentrations in acute and chronic morphine-treated rats.
    Ko WW; Dai S
    Clin Exp Pharmacol Physiol; 1989 Feb; 16(2):117-20. PubMed ID: 2714019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine tissue levels and reduction of gastrointestinal transit in rats. Correlation supports primary action site in the gut.
    Bianchi G; Ferretti P; Recchia M; Rocchetti M; Tavani A; Manara L
    Gastroenterology; 1983 Oct; 85(4):852-8. PubMed ID: 6193028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tripelennamine effects on body and organ weights, water intake, and several behaviors of rats.
    Nanry KP; Sewell RG; Gallus JA; Vanecek SA; Poling A
    Pharmacol Biochem Behav; 1983 Nov; 19(5):821-5. PubMed ID: 6647516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tripelennamine: enhancement of brain-stimulation reward.
    Unterwald EM; Kucharski LT; Williams JE; Kornetsky C
    Life Sci; 1984 Jan; 34(2):149-53. PubMed ID: 6607395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of morphine in rat brain: relationship to biological activity.
    Plomp GJ; Maes RA; van Ree JM
    J Pharmacol Exp Ther; 1981 Apr; 217(1):181-8. PubMed ID: 7205651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the properties of brain opiate receptors during the development of morphine tolerance in rats].
    Zaĭtsev SV; Sergeeva MG; Chichenkov ON; Petrov VE; Varfolomeev SD
    Biokhimiia; 1986 Aug; 51(8):1334-40. PubMed ID: 3021240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.